|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:ADCY2-CASC3 (FusionGDB2 ID:2214) |
Fusion Gene Summary for ADCY2-CASC3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ADCY2-CASC3 | Fusion gene ID: 2214 | Hgene | Tgene | Gene symbol | ADCY2 | CASC3 | Gene ID | 108 | 22794 |
| Gene name | adenylate cyclase 2 | CASC3 exon junction complex subunit | |
| Synonyms | AC2|HBAC2 | BTZ|MLN51 | |
| Cytomap | 5p15.31 | 17q21.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | adenylate cyclase type 23',5'-cyclic AMP synthetaseATP pyrophosphate-lyase 2adenylate cyclase 2 (brain)adenylate cyclase IIadenylate cyclase type IIadenylyl cyclase 2type II adenylate cyclase | protein CASC3MLN 51barentszcancer susceptibility 3cancer susceptibility candidate 3cancer susceptibility candidate gene 3 proteinmetastatic lymph node 51metastatic lymph node gene 51 proteinprotein barentsz | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q08462 | O15234 | |
| Ensembl transtripts involved in fusion gene | ENST00000338316, ENST00000513693, ENST00000537121, | ENST00000264645, | |
| Fusion gene scores | * DoF score | 11 X 9 X 6=594 | 10 X 5 X 5=250 |
| # samples | 10 | 10 | |
| ** MAII score | log2(10/594*10)=-2.57046293102604 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/250*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ADCY2 [Title/Abstract] AND CASC3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | ADCY2(7414883)-CASC3(38318006), # samples:2 CASC3(38323114)-ADCY2(7414686), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | CASC3 | GO:0000398 | mRNA splicing, via spliceosome | 29301961 |
| Fusion gene breakpoints across ADCY2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across CASC3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | CESC | TCGA-MA-AA43-01A | ADCY2 | chr5 | 7414883 | + | CASC3 | chr17 | 38318006 | + |
| ChimerDB4 | CESC | TCGA-MA-AA43 | ADCY2 | chr5 | 7414883 | + | CASC3 | chr17 | 38318006 | + |
Top |
Fusion Gene ORF analysis for ADCY2-CASC3 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000338316 | ENST00000264645 | ADCY2 | chr5 | 7414883 | + | CASC3 | chr17 | 38318006 | + |
| intron-3CDS | ENST00000513693 | ENST00000264645 | ADCY2 | chr5 | 7414883 | + | CASC3 | chr17 | 38318006 | + |
| intron-3CDS | ENST00000537121 | ENST00000264645 | ADCY2 | chr5 | 7414883 | + | CASC3 | chr17 | 38318006 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000338316 | ADCY2 | chr5 | 7414883 | + | ENST00000264645 | CASC3 | chr17 | 38318006 | + | 4090 | 497 | 89 | 2311 | 740 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000338316 | ENST00000264645 | ADCY2 | chr5 | 7414883 | + | CASC3 | chr17 | 38318006 | + | 0.003075718 | 0.9969242 |
Top |
Fusion Genomic Features for ADCY2-CASC3 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| ADCY2 | chr5 | 7414883 | + | CASC3 | chr17 | 38318005 | + | 7.55E-07 | 0.9999993 |
| ADCY2 | chr5 | 7414883 | + | CASC3 | chr17 | 38318005 | + | 7.55E-07 | 0.9999993 |
| ADCY2 | chr5 | 7414883 | + | CASC3 | chr17 | 38318005 | + | 7.55E-07 | 0.9999993 |
| ADCY2 | chr5 | 7414883 | + | CASC3 | chr17 | 38318005 | + | 7.55E-07 | 0.9999993 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for ADCY2-CASC3 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:7414883/chr17:38318006) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ADCY2 | CASC3 |
| FUNCTION: Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling (PubMed:15385642). Down-stream signaling cascades mediate changes in gene expression patterns and lead to increased IL6 production. Functions in signaling cascades downstream of the muscarinic acetylcholine receptors (By similarity). {ECO:0000250|UniProtKB:P26769, ECO:0000269|PubMed:15385642}. | FUNCTION: Required for pre-mRNA splicing as component of the spliceosome (PubMed:28502770, PubMed:29301961). Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). Stimulates the ATPase and RNA-helicase activities of EIF4A3. Plays a role in the stress response by participating in cytoplasmic stress granules assembly and by favoring cell recovery following stress. Component of the dendritic ribonucleoprotein particles (RNPs) in hippocampal neurons. May play a role in mRNA transport. Binds spliced mRNA in sequence-independent manner, 20-24 nucleotides upstream of mRNA exon-exon junctions. Binds poly(G) and poly(U) RNA homopolymer. {ECO:0000269|PubMed:17375189, ECO:0000269|PubMed:17652158, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 1_45 | 136 | 1092.0 | Topological domain | Cytoplasmic |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 108_128 | 136 | 1092.0 | Transmembrane | Helical |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 46_66 | 136 | 1092.0 | Transmembrane | Helical |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 76_96 | 136 | 1092.0 | Transmembrane | Helical |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 392_395 | 99 | 1130.6666666666667 | Compositional bias | Note=Poly-Pro | |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 425_428 | 99 | 1130.6666666666667 | Compositional bias | Note=Poly-Pro | |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 643_648 | 99 | 1130.6666666666667 | Compositional bias | Note=Poly-Pro | |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 692_695 | 99 | 1130.6666666666667 | Compositional bias | Note=Poly-Pro | |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 204_210 | 99 | 1130.6666666666667 | Motif | Nuclear localization signal 1 | |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 254_262 | 99 | 1130.6666666666667 | Motif | Nuclear localization signal 2 | |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 462_466 | 99 | 1130.6666666666667 | Motif | Note=Nuclear export signal | |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 137_283 | 99 | 1130.6666666666667 | Region | Note=Sufficient to form the EJC | |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 377_703 | 99 | 1130.6666666666667 | Region | Note=Necessary for localization in cytoplasmic stress granules |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 1019_1021 | 136 | 1092.0 | Nucleotide binding | ATP |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 1026_1030 | 136 | 1092.0 | Nucleotide binding | ATP |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 295_300 | 136 | 1092.0 | Nucleotide binding | ATP |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 337_339 | 136 | 1092.0 | Nucleotide binding | ATP |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 208_601 | 136 | 1092.0 | Topological domain | Cytoplasmic |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 822_1091 | 136 | 1092.0 | Topological domain | Cytoplasmic |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 133_153 | 136 | 1092.0 | Transmembrane | Helical |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 159_179 | 136 | 1092.0 | Transmembrane | Helical |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 187_207 | 136 | 1092.0 | Transmembrane | Helical |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 602_622 | 136 | 1092.0 | Transmembrane | Helical |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 628_652 | 136 | 1092.0 | Transmembrane | Helical |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 680_701 | 136 | 1092.0 | Transmembrane | Helical |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 734_755 | 136 | 1092.0 | Transmembrane | Helical |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 763_780 | 136 | 1092.0 | Transmembrane | Helical |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 801_821 | 136 | 1092.0 | Transmembrane | Helical |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 95_131 | 99 | 1130.6666666666667 | Coiled coil | Ontology_term=ECO:0000255 | |
| Tgene | CASC3 | chr5:7414883 | chr17:38318006 | ENST00000264645 | 2 | 14 | 41_46 | 99 | 1130.6666666666667 | Compositional bias | Note=Poly-Gly |
Top |
Fusion Gene Sequence for ADCY2-CASC3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >2214_2214_1_ADCY2-CASC3_ADCY2_chr5_7414883_ENST00000338316_CASC3_chr17_38318006_ENST00000264645_length(transcript)=4090nt_BP=497nt AGGCGGCGCGGGGGTGGGACGCGGGCGGCCGCGGCGAGCGGCGCTGCCCGGGCCGGGCGCGCACGGCGGGCGCCCTGTGAGCGGCCCCGA TGTGGCAGGAGGCGATGCGGCGCCGCCGCTACCTGCGGGACCGCTCCGAGGAGGCGGCGGGCGGCGGAGACGGGCTGCCGCGGTCCCGGG ACTGGCTCTACGAGTCCTACTACTGCATGAGCCAGCAGCACCCGCTCATCGTCTTCCTGCTGCTCATCGTCATGGGCTCCTGCCTCGCCC TGCTCGCCGTCTTCTTCGCGCTCGGGCTGGAAGTTGAAGACCATGTGGCGTTTCTAATAACAGTTCCAACTGCCCTGGCGATTTTCTTTG CGATATTTATCCTGGTCTGCATCGAGTCTGTGTTTAAGAAGCTGCTGCGCCTCTTCTCGTTGGTGATATGGATATGCCTTGTTGCCATGG GATACCTGTTCATGTGTTTTGGAGGCACCGTCTCTCCCTGGGACCAGGGTGAAGAAGGTGAATACAGTGAAGAGGAAAACTCCAAAGTGG AGCTGAAATCAGAAGCTAATGATGCTGTTAATTCTTCAACAAAAGAAGAGAAGGGAGAAGAAAAGCCTGACACCAAAAGCACTGTGACTG GAGAGAGGCAAAGTGGGGACGGACAGGAGAGCACAGAGCCTGTGGAGAACAAAGTGGGTAAAAAGGGCCCTAAGCATTTGGATGATGATG AAGATCGGAAGAATCCAGCATACATACCTCGGAAAGGGCTCTTCTTTGAGCATGATCTTCGAGGGCAAACTCAGGAGGAGGAAGTCAGAC CCAAGGGGCGTCAGCGAAAGCTATGGAAGGATGAGGGTCGCTGGGAGCATGACAAGTTCCGGGAAGATGAGCAGGCCCCAAAGTCCCGAC AGGAGCTCATTGCTCTTTATGGTTATGACATTCGCTCAGCTCATAATCCTGATGACATCAAACCTCGAAGAATCCGGAAACCCCGATATG GGAGTCCTCCACAAAGAGATCCAAACTGGAACGGTGAGCGGCTAAACAAGTCTCATCGCCACCAGGGTCTTGGGGGCACCCTACCACCAA GGACATTTATTAACAGGAATGCTGCAGGTACCGGCCGTATGTCTGCACCCAGGAATTATTCTCGATCTGGGGGCTTCAAGGAAGGTCGTG CTGGTTTTAGGCCTGTGGAAGCTGGTGGGCAGCATGGTGGCCGGTCTGGTGAGACTGTTAAGCATGAGATTAGTTACCGGTCACGGCGCC TAGAGCAGACTTCTGTGAGGGATCCATCTCCAGAAGCAGATGCTCCAGTGCTTGGCAGTCCTGAGAAGGAAGAGGCAGCCTCAGAGCCAC CAGCTGCTGCTCCTGATGCTGCACCACCACCCCCTGATAGGCCCATTGAGAAGAAATCCTATTCCCGGGCAAGAAGAACTCGAACCAAAG TTGGAGATGCAGTCAAGCTTGCAGAGGAGGTGCCCCCTCCTCCTGAAGGACTGATTCCAGCACCTCCAGTCCCAGAAACCACCCCAACTC CACCTACTAAGACTGGGACCTGGGAAGCTCCGGTGGATTCTAGTACAAGTGGACTTGAGCAAGATGTGGCACAACTAAATATAGCAGAAC AGAATTGGAGTCCGGGGCAGCCTTCTTTCCTGCAACCACGGGAACTTCGAGGTATGCCCAACCATATACACATGGGAGCAGGACCTCCAC CTCAGTTTAACCGGATGGAAGAAATGGGTGTCCAGGGTGGTCGAGCCAAACGCTATTCATCCCAGCGGCAAAGACCTGTGCCAGAGCCCC CCGCCCCTCCAGTGCATATCAGTATCATGGAGGGACATTACTATGATCCACTGCAGTTCCAGGGACCAATCTATACCCATGGTGACAGCC CTGCCCCGCTGCCTCCACAGGGCATGCTTGTGCAGCCAGGAATGAACCTTCCCCACCCAGGTTTACATCCCCACCAGACACCAGCTCCTC TGCCCAATCCAGGCCTCTATCCCCCACCAGTGTCCATGTCTCCAGGACAGCCACCACCTCAGCAGTTGCTTGCTCCTACTTACTTTTCTG CTCCAGGCGTCATGAACTTTGGTAATCCCAGTTACCCTTATGCTCCAGGGGCACTGCCTCCCCCACCACCGCCTCATCTGTATCCTAATA CACAGGCCCCATCACAGGTATATGGAGGAGTGACCTACTATAACCCCGCCCAGCAGCAGGTGCAGCCAAAGCCCTCCCCACCCCGGAGGA CTCCCCAGCCAGTCACCATCAAGCCCCCTCCACCTGAGGTTGTAAGCAGGGGTTCCAGTTAATACAAGTTTCTGAATATTTTAAATCTTA ACATCATATAAAAAGCAGCAGAGGTGAGAACTCAGAAGAGAAATACAGCTGGCTATCTACTACCAGAAGGGCTTCAAAGATATAGGGTGT GGCTCCTACCAGCAAACAGCTGAAAGAGGAGGACCCCTGCCTTCCTCTGAGGACAGGCTCTAGAGAGAGGGAGAAACAAGTGGACCTCGT CCCATCTTCACTCTTCACTTGAGTTGGCTGTGTTCGGGGGAGCAGAGAGAGCCAGACAGCCCCAAGCTTCTGAGTCTAGATACAGAAGCC CATGTCTTCTGCTGTTCTTCACTTCTGGGAAATTGAAGTGTCTTCTGTTCCCAAGGAAGCTCCTTCCTGTTTGTTTTGTTTTCTAAGATG TTCATTTTTAAAGCCTGGCTTCTTATCCTTAATATTATTTTAATTTTTTCTCTTTGTTTCTGTTTCTTGCTCTCTCTCCCTGCCTTTAAA TGAAACAAGTCTAGTCTTCTGGTTTTCTAGCCCCTCTGGATTCCCTTTTGACTCTTCCGTGCATCCCAGATAATGGAGAATGTATCAGCC AGCCTTCCCCACCAAGTCTAAAAAGACCTGGCCTTTCACTTTTAGTTGGCATTTGTTATCCTCTTGTATACTTGTATTCCCTTAACTCTA ACCCTGTGGAAGCATGGCTGTCTGCACAGAGGGTCCCATTGTGCAGAAAAGCTCAGAGTAGGTGGGTAGGAGCCCTTCTCTTTGACTTAG GTTTTTAGGAGTCTGAGCATCCATCAATACCTGTACTATGATGGGCTTCTGTTCTCTGCTGAGGGCCAATACCCTACTGTGGGGAGAGAT GGCACACCAGATGCTTTTGTGAGAAAGGGATGGTGGAGTGAGAGCCTTTGCCTTTAGGGGTGTGTATTCACATAGTCCTCAGGGCTCAGT CTTTTGAGGTAAGTGGAATTAGAGGGCCTTGCTTCTCTTCTTTCCATTCTTCTTGCTACACCCCTTTTCCAGTTGCTGTGGACCAATGCA TCTCTTTAAAGGCAAATATTATCCAGCAAGCAGTCTACCCTGTCCTTTGCAATTGCTCTTCTCCACGTCTTTCCTGCTACAAGTGTTTTA GATGTTACTACCTTATTTTCCCCGAATTCTATTTTTGTCCTTGCAGACAGAATATAAAAACTCCTGGGCTTAAGGCCTAAGGAAGCCAGT CACCTTCTGGGCAAGGGCTCCTATCTTTCCTCCCTATCCATGGCACTAAACCACTTCTCTGCTGCCTCTGTGGAAGAGATTCCTATTACT GCAGTACATACGTCTGCCAGGGGTAACCTGGCCACTGTCCCTGTCCTTCTACAGAACCTGAGGGCAAAGATGGTGGCTGTGTCTCTCCCC GGTAATGTCACTGTTTTTATTCCTTCCATCTAGCAGCTGGCCTAATCACTCTGAGTCACAGGTGTGGGATGGAGAGTGGGGAGAGGCACT TAATCTGTAACCCCCAAGGAGGAAATAACTAAGAGATTCTTCTAGGGGTAGCTGGTGGTTGTGCCTTTTGTAGGCTGTTCCCTTTGCCTT AAACCTGAAGATGTCTCCTCAAGCCTGTGGGCAGCATGCCCAGATTCCCAGACCTTAAGACACTGTGAGAGTTGTCTCTGTTGGTCCACT GTGTTTAGTTGCAAGGATTTTTCCATGTGTGGTGGTGTTTTTTGTTACTGTTTTAAAGGGTGCCCATTTGTGATCAGCATTGTGACTTGG >2214_2214_1_ADCY2-CASC3_ADCY2_chr5_7414883_ENST00000338316_CASC3_chr17_38318006_ENST00000264645_length(amino acids)=740AA_BP=135 MWQEAMRRRRYLRDRSEEAAGGGDGLPRSRDWLYESYYCMSQQHPLIVFLLLIVMGSCLALLAVFFALGLEVEDHVAFLITVPTALAIFF AIFILVCIESVFKKLLRLFSLVIWICLVAMGYLFMCFGGTVSPWDQGEEGEYSEEENSKVELKSEANDAVNSSTKEEKGEEKPDTKSTVT GERQSGDGQESTEPVENKVGKKGPKHLDDDEDRKNPAYIPRKGLFFEHDLRGQTQEEEVRPKGRQRKLWKDEGRWEHDKFREDEQAPKSR QELIALYGYDIRSAHNPDDIKPRRIRKPRYGSPPQRDPNWNGERLNKSHRHQGLGGTLPPRTFINRNAAGTGRMSAPRNYSRSGGFKEGR AGFRPVEAGGQHGGRSGETVKHEISYRSRRLEQTSVRDPSPEADAPVLGSPEKEEAASEPPAAAPDAAPPPPDRPIEKKSYSRARRTRTK VGDAVKLAEEVPPPPEGLIPAPPVPETTPTPPTKTGTWEAPVDSSTSGLEQDVAQLNIAEQNWSPGQPSFLQPRELRGMPNHIHMGAGPP PQFNRMEEMGVQGGRAKRYSSQRQRPVPEPPAPPVHISIMEGHYYDPLQFQGPIYTHGDSPAPLPPQGMLVQPGMNLPHPGLHPHQTPAP LPNPGLYPPPVSMSPGQPPPQQLLAPTYFSAPGVMNFGNPSYPYAPGALPPPPPPHLYPNTQAPSQVYGGVTYYNPAQQQVQPKPSPPRR -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ADCY2-CASC3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 905_922 | 136.0 | 1092.0 | GNAS |
| Hgene | ADCY2 | chr5:7414883 | chr17:38318006 | ENST00000338316 | + | 2 | 25 | 990_993 | 136.0 | 1092.0 | GNAS |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ADCY2-CASC3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ADCY2-CASC3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies